D-0874-2022 Class II Terminated
Recall Details
- Product Type
- Drugs
- Report Date
- May 25, 2022
- Initiation Date
- April 22, 2022
- Termination Date
- October 5, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 8346 bottles
Product Description
Accupril (Quinapril HCl Tablets) 40 mg, 90 Tablets, Rx only NDC 0071-0535-23 Distributed by: Parke-Davis Division of Pfizer Inc. NY, NY 10017
Reason for Recall
CGMP Deviations: Contains N-nitrosoquinapril above the acceptable limits.
Distribution Pattern
Nationwide and Puerto Rico
Code Information
Lots: DX6031 Exp. MAR 31 2023; CK6260 Exp. MAY 31 2022